Cargando…
Amino Acid Degrading Enzymes and Autophagy in Cancer Therapy
Recently, there has been renewed interest in metabolic therapy for cancer, particularly in amino acid deprivation by enzymes. L-asparaginase was approved for the treatment of acute lymphoblastic leukemia by the U.S. Food and Drug Administration. Arginine deiminase and recombinant human arginase have...
Autores principales: | Wang, Ziyu, Xie, Qinghong, Zhou, Haifeng, Zhang, Min, Shen, Jie, Ju, Dianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836011/ https://www.ncbi.nlm.nih.gov/pubmed/33510635 http://dx.doi.org/10.3389/fphar.2020.582587 |
Ejemplares similares
-
Bruceae Fructus Oil Inhibits Triple-Negative Breast Cancer by Restraining Autophagy: Dependence on the Gut Microbiota-Mediated Amino Acid Regulation
por: Su, Jiyan, et al.
Publicado: (2021) -
EGCG identified as an autophagy inducer for rosacea therapy
por: Zhou, Lei, et al.
Publicado: (2023) -
The crosstalk between sonodynamic therapy and autophagy in cancer
por: Zhang, Yujie, et al.
Publicado: (2022) -
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
por: Qi, Si-Min, et al.
Publicado: (2021) -
Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy
por: Liu, Ting, et al.
Publicado: (2020)